IP Australia puts kibosh on extension for Bayer’s contraceptive patent

Davies Collison Cave 2022-02-08 10:56 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

IP Australia has quashed an extension for a patent covering a Bayer oral contraceptive, saying the extension should have been calculated based on a drug that was included on the Australian Register of Therapeutic Goods at an earlier date.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au